Patent · US Active

Methods and compositions for increasing the efficiency of therapeutic antibodies using NK cell potentiating compounds

US9090876B2 · kind B2 · utility

12Cited by
2References
58Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 30, 2010
Grant dateJul 28, 2015
Priority date
Expiry dateDec 11, 2030

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, generally, to methods and compositions for increasing the efficiency of therapeutic antibodies. Their efficiency is enhanced through the increase of the ADCC mechanism. More particularly, the invention relates to the use of a therapeutic antibody in combination with compounds that block an inhibitory receptor or stimulate an activating receptor of an NK cell in order to enhance the efficiency of the treatment with therapeutic antibodies in human subjects.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.